New year, new job? View the vacancies! More ...

All publications from Vetter Pharma International GmbH

L to R: Harald Bader, Sylke Wassung, Thomas Otto, Oliver Albrecht, Thomas Rübekeil, Christian Schmid, Dr. Daniel Rapp, Gunther Strothe, Udo J. Vetter at the ceremonial laying of the foundation stone at the Ravensburg location Schützenstraße.

01.10.2017

Vetter lays the foundation stone for a new administrative building

With the ceremonial groundbreaking, Vetter yesterday officially launched the construction of a new administrative building at the Ravensburg location on Schützenstrasse, which is scheduled to be completed by mid-2019. The construction is part of an ongoing investment package to further develop the…

Cooperation for innovative injectable administration (from left to right): Dr. Claus Feußner, Senior Vice President Vetter Development Service; Prof. Boris Stoeber, Co-founder and Technology Officer; Grant Campany, President and CEO (both Microdermics); and Dr. David Brett, Team Leader Product and Service Management at Vetter.
(Source: Vetter Pharma International GmbH / Microdermics Inc.) / Vetter and Microdermics join forces for innovation in drug delivery. From left to right: Dr. Claus Feussner, Senior Vice President Vetter Development Service; Prof. Boris Stoeber, Co-founder and Chief Technical Officer; Grant Campany, President & CEO (both Microdermics); and Dr. David Brett, Team Leader Product and Service Management at Vetter. (Picture source: Vetter Pharma International GmbH / Microdermics Inc.)

07.06.2017

Vetter and Microdermics Enter into a Strategic Cooperation Agreement to Develop Innovative Microneedle Drug Delivery Systems

Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal microneedle drug and vaccine delivery system, today announced that they have entered into a strategic cooperation agre…

Now on the advisory board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA in Stuttgart, Process Industry Division: Dr. Claudia Roth, Vetter Vice President of Innovation Management. (Source: Vetter Pharma International GmbH) /

31.03.2017

Appointment will allow for active involvement within the Fraunhofer Institute for Manufacturing Engineering and Automation IPA

Vetter’s Dr. Claudia Roth is appointed to the Fraunhofer Advisory Board

Dr. Claudia Roth, Vice President for Vetter’s department of Innovation Management, has been appointed to the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA in Stuttgart. Over the next two years, Dr. Roth will be active in the Process Industry business u…

Overview of the aseptic clinical filling of syringe systems at the US site in Chicago. (Source: Vetter Pharma International GmbH)

14.12.2016

The pharmaceutical service provider is preparing for increasing customer demand for pre-filled syringes with additional storage capacities

Increasing clinical syringe fillings at the Vetter US location in Chicago

Vetter, an internationally leading Contract Development and Manufacturing Organization (CDMO) in the field of aseptically pre-filled injection systems, has already produced clinical batches in the double digits for early clinical trials of its customers on its new syringe line at the US site in Chic…

The Vetter project team with Troy Carpenter (President of Vetter Pharma International USA - third from right), Casie Thomas (US Key Account Manager), Martin Schwab (Customer Project Manager - second from left), and Alexander Osswald (Team Leader Central Planning - far left) at the award ceremony in April 2016, together with AbbVie's Terry Simmons (Vice President of Purchasing - second from right) and Jose Sevilla (Program Director - far right). / Troy Carpenter (President of Vetter Pharma International USA - third from right), Casie Thomas (US Key Account Manager), Martin Schwab (Customer Project Manager - second from left), and Alexander Osswald (Team Leader Central Planning - first from left) accepted the award in a ceremony in April 2016 representing the Vetter project team. They are joined by AbbVie's Terry Simmons (Vice President of Procurement - second from right), and Jose Sevilla (Program Director - first from right).

12.05.2016

Leading CDMO claims prestigious customer award from one of the top-20 biopharmaceutical companies

Vetter is a winner of the AbbVie TRIUMPH AWARD

AbbVie, one of the world’s leading biopharmaceutical companies has awarded Vetter, a leading contract manufacturing and development organization (CDMO), the TRIUMPH AWARD for 2015. The award was granted for meeting AbbVie’s ‘predetermined high-level demands of service’. Vetter received this…

Ceremonial groundbreaking for the new production building at the Schützenstraße site (from left to right): Peter Sölkner, Oliver Albrecht, Harald Bader, Thomas Rübekeil, Udo J. Vetter, Dr. Daniel Rapp, Thomas Otto, Gunther Strothe, Wolfgang Kerkhoff, Christian Schmid. / Working together to break ground for the new production building within the Vetter Schützenstraße production site (from left to right): Peter Soelkner, Oliver Albrecht, Harald Bader, Thomas Ruebekeil, Udo J. Vetter, Dr. Daniel Rapp, Thomas Otto, Gunther Strothe, Wolfgang Kerkhoff, Christian Schmid.

01.04.2016

New construction represents an important component of a previously announced investment strategy

Creation of a new 70 million euro Vetter production building

Vetter, a leading global contract development and manufacturing organization (CDMO) for the development, commercial manufacturing and final packaging of aseptically prefilled drug-delivery systems, today announced the construction of a new building at a ground breaking ceremony held at its Ravensbur…

View of the completed multifunctional building at the Ravensburg production site Schützenstraße.

11.02.2016

Positive business development and company growth continue in 2015

Vetter completes new multifunction building for Development Service and IT

The pharmaceutical service provider Vetter has constructed a new multifunctional building at the Schützenstraße location within the planned timeframe of nearly two years. The building was constructed due to increasing customer demand for support in drug development and the need for advanced inform…

04.12.2015

Pharmaceutical service providers and customers benefit from comprehensive customs advantages

Vetter receives internationally recognized AEO-F certificate for global goods traffic

Vetter has received the status of Authorized Economic Operator Full (AEO-F) from the European Union. The certificate certifies Vetter's reliability, solvency, and high security standards in international trade. Vetter's customers worldwide benefit from shorter transport times and lower costs while m…

Dr. Hitoshi Kuboniwa (Senior Vice President and General Manager of the Pharmaceutical Technologies Division, Chugai Pharmaceutical Co., Ltd.) and Peter Sölkner (Managing Director of Vetter) at the inauguration ceremony on the occasion of the opening of the Japanese sales subsidiary Vetter Pharma International Japan K.K. (from left to right).

16.10.2015

Second location in Asia aims to strengthen Japanese customer relationships and promote new business

Vetter opens sales branch in Japan

Vetter, one of the world's leading pharmaceutical service providers for the sterile filling and packaging of injection systems, announced today during a ceremony on-site the opening of its new sales branch in Tokyo. Customers, partner companies, and industry representatives were invited to the event…

Completed shell construction: Part of the 300 million euro investment is allocated to the expansion of the Center for Optical Inspection and Logistics at the Ravensburg Vetter West site.

06.10.2015

First activities resulting from the investment already underway

Vetter Embarks on a 300 Million Euro Investment Strategy for Further Development To its Manufacturing Sites and to make available Additional Manufacturing Capacities

Vetter has announced that in keeping with its commitment to providing customers with the manufacture of high quality drug products, the company will invest approximately 300 million euros to expand and upgrade its manufacturing facilities over an estimated five-year period. As a leading contract dev…

A look at the NEWSLETTER

Better informed: With YEARBOOK, NEWSLETTER, NEWSFLASH, NEWSEXTRA and EXPERT DIRECTORY

Stay up to date and subscribe to our monthly eMail-NEWSLETTER and our NEWSFLASH and NEWSEXTRA. Get additional information about what is happening in the world of cleanrooms with our printed YEARBOOK. And find out who the cleanroom EXPERTS are with our directory.